2370 On Other Exchanges
Symbol
Exchange
2370 is not on other exchanges.

medinet co ltd (2370) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDINET CO LTD (2370)
\

Related News

No related news articles were found.

medinet co ltd (2370) Related Businessweek News

No Related Businessweek News Found

medinet co ltd (2370) Details

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy. The company offers manufacturing solutions for regenerative medical products/investigational products and specified cell products; and value chain solutions, including technology transfer and process development, quality control and assurance, logistics, etc. It provides various types of immuno-cell therapy, such as dendritic cell vaccine therapy, natural killer-cell therapy, gamma-delta T-cell therapy, alpha-beta T-cell therapy, and cytotoxic T-lymphocyte therapy. The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was founded in 1995 and is headquartered in Yokohama, Japan.

156 Employees
Last Reported Date: 12/27/17
Founded in 1995

medinet co ltd (2370) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medinet co ltd
MEDINET Co., Ltd. Reports Consolidated Earnings Results for the First Half Year Ended of March 2018; Provides Earnings Guidance for the Year Ending of September 2018

MEDINET Co., Ltd. reported consolidated earnings results for the first half year ended of March 2018. For the half year, the company reported net sales of JPY 542 million compared to JPY 893 million a year ago. Operating loss was JPY 1,914 million compared to JPY 1,036 million a year ago. Ordinary loss was JPY 1,959 million compared to JPY 976 million a year ago. Loss attributable to owners of parent was JPY 2,104 million compared to JPY 991 million a year ago. Basic loss per share was JPY 19.18 compared to JPY 10.70 a year ago. The company provided earnings guidance for the year ending of September 2018. For the year, the company expects net sales to be of JPY 960 million. Operating loss expected to be of JPY 3,071 million. Ordinary loss expected to be of JPY 3,108 million. Loss attributable to owners of parent expected to be of JPY 3,404 million. Basic loss per share expected to be of JPY 29.36.

MEDINET Co., Ltd. to Report Q2, 2018 Results on May 08, 2018

MEDINET Co., Ltd. announced that they will report Q2, 2018 results on May 08, 2018

MEDINET Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended December 31, 2017; Provides Consolidated Earnings Guidance for the Year Ending September 30, 2018

MEDINET Co., Ltd. reported consolidated earnings results for the first quarter ended December 31, 2017. For the quarter, the company reported net sales of JPY 295 million against JPY 451 million a year ago. Operating loss of JPY 1,523 million against JPY 414 million a year ago. Ordinary loss of JPY 1,502 million against JPY 302 million a year ago. Loss attributable to owners of parent was JPY 1,125 million against JPY 307 million a year ago. Basic loss per share was JPY 10.34 against JPY 3.32 a year ago. For the fiscal year ending September 2018, the company expects consolidated net sales of JPY 1,970 million, operating loss of JPY 1,400 million, ordinary loss of JPY 1,384 million, loss attributable to owners of parent of JPY 1,395 million and basic loss per share of JPY 12.88.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

2370 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2370.
View Industry Companies
 

Industry Analysis

2370

Industry Average

Valuation 2370 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.8x
Price/Book 2.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MEDINET CO LTD, please visit www.medinet-inc.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.